Table 1. Clinicopathological characteristics of patients with prostate cancer and their association with ESCO1 expression.

Parameter	ESCO1 expression		P value
	High	Low
Age, years			0.311
<60	9	11
≥60	54	40
Lymph node metastasis			0.012*
Absence	44	46
Presence	19	5
Surgical margin status			0.872
Absence	55	44
Presence	8	7
Seminal vesicle invasion			0.822
Absence	56	46
Presence	7	5
PSA, ng/mL			0.001*
≤10	4	5
10-20	35	11
>20	24	35
TNM stage			0.026*
I	28	33
II	23	16
III	5	1
IV	7	1
Gleason score			<0.001*
<7	1	10
7 (3+4)	1	19
7 (4+3)	2	12
>7	59	10
Biochemical recurrence			<0.001*
Absence	15	8
Presence	48	43

*, indicates a statistically significant result. ESCO1, establishment of sister chromatid cohesion N-acetyltransferase 1; PSA, prostate-specific antigen.